Stock Library / MDLN

MDLN Unclassified Latest YouTube: Q2 2026 Published 2026-08-05

MDLN

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest on YouTube Latest on Spotify Latest on Podbean Apple Podcasts Amazon Music iHeartRadio YouTube Music Company Website Back to Library

Latest earnings video

Medline (MDLN): They Beat By 52%. The Beat Was A Tariff Refund.

Published 2026-08-05

Open YouTube Open Spotify Open Podbean Apple Podcasts

Library coverage

Episodes tracked

1

Episodes linked

1

Latest video

Q2 2026

2026-08-05

Podcast available

Yes

Current price

$34.51

-1.82 (-5.01%)

Trailing / Forward P/E

30.27x

Forward: 21.27x

Market cap / Volume

—

Volume: —

Revenue / Earnings Growth

11.6%

Earnings: 267.9%

Margins

5.1% op

Gross: 26.2% · Net: 2.3%

Balance sheet

4.33x current

Debt / Equity: 65.9

52-week range / Beta

$32.81 - $50.88

Beta: —

Analyst target

$50.65

Upside: 46.8%

Cash / shareholder return

3.52% FCF yield

Dividend yield: —

Company context

Industry: Medical Instruments & Supplies

Country: United States

Employees: —

Price to book: 2.62x

Return on equity: 4.9%

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Price chart

Market context for MDLN

Competitive view

MDLN vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

MDLN latest YouTube video thumbnail

MDLN

MDLN

YouTube Spotify Podbean

Latest video

Q2 2026

Growth profile looks strong right now, with above-average top-line and/or earnings momentum.

Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.

Consensus analyst targets still imply meaningful upside, suggesting the Street thinks the current price leaves room for appreciation.

Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.

SS&C Technologies Holdings Inc. latest YouTube video thumbnail

SS&C Technologies Holdings Inc.

SSNC

YouTube Podbean

Latest video

Q2 2026

Growth profile looks strong right now, with above-average top-line and/or earnings momentum.

Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.

Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.

Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.

Palantir Technologies latest YouTube video thumbnail

Palantir Technologies

PLTR

YouTube Podbean

Latest video

Q2 2026

Growth profile looks strong right now, with above-average top-line and/or earnings momentum.

Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.

Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.

Expect a more volatile ride than the market average; that can amplify upside, but drawdowns can come fast too.

Market Cap

More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.

MDLN

$29.18B

MDLN

SSNC

$18.73B

SS&C Technologies Holdings Inc.

PLTR

$374.68B

Palantir Technologies

Trailing P/E

Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.

MDLN

30.3x

MDLN

SSNC

22.9x

SS&C Technologies Holdings Inc.

PLTR

175.2x

Palantir Technologies

Forward P/E

Forward P/E is often a better read on what investors are paying for the next year of earnings power.

MDLN

21.3x

MDLN

SSNC

10.3x

SS&C Technologies Holdings Inc.

PLTR

68.9x

Palantir Technologies

Revenue Growth

Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.

MDLN

11.6%

MDLN

SSNC

10.3%

SS&C Technologies Holdings Inc.

PLTR

92.8%

Palantir Technologies

Earnings Growth

Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.

MDLN

267.9%

MDLN

SSNC

34.7%

SS&C Technologies Holdings Inc.

PLTR

215.4%

Palantir Technologies

Operating Margin

Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.

MDLN

5.1%

MDLN

SSNC

24.6%

SS&C Technologies Holdings Inc.

PLTR

47.1%

Palantir Technologies

Gross Margin

Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.

MDLN

26.2%

MDLN

SSNC

48.1%

SS&C Technologies Holdings Inc.

PLTR

84.8%

Palantir Technologies

Net Margin

Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.

MDLN

2.3%

MDLN

SSNC

13.2%

SS&C Technologies Holdings Inc.

PLTR

49.0%

Palantir Technologies

Return on Equity

ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.

MDLN

4.9%

MDLN

SSNC

12.6%

SS&C Technologies Holdings Inc.

PLTR

38.1%

Palantir Technologies

Free Cash Flow Yield

Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.

MDLN

3.5%

MDLN

SSNC

7.0%

SS&C Technologies Holdings Inc.

PLTR

0.6%

Palantir Technologies

Debt to Equity

Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.

MDLN

65.93x

MDLN

SSNC

115.90x

SS&C Technologies Holdings Inc.

PLTR

2.14x

Palantir Technologies

Current Ratio

A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.

MDLN

4.33x

MDLN

SSNC

1.06x

SS&C Technologies Holdings Inc.

PLTR

7.23x

Palantir Technologies

Beta

Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.

MDLN

—

MDLN

SSNC

1.09

SS&C Technologies Holdings Inc.

PLTR

1.56

Palantir Technologies

Dividend Yield

Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.

MDLN

—

MDLN

SSNC

1.4%

SS&C Technologies Holdings Inc.

PLTR

—

Palantir Technologies

Analyst Upside

Higher analyst upside suggests the Street still sees room between current price and consensus fair value.

MDLN

46.8%

MDLN

SSNC

15.6%

SS&C Technologies Holdings Inc.

PLTR

21.1%

Palantir Technologies

Related research

Non-quarter videos featuring MDLN

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections

Shorts and Clips 2026-08-05

Medline Beat By 52%. The Beat Was A Tariff Refund. #MDLN

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

YouTube

Episode timeline

Episode archive for MDLN

Each row is one earnings episode with every verified platform link available.

Q2 2026

Episode live

2026-08-05

Published youtube podcast complete

Medline (MDLN): They Beat By 52%. The Beat Was A Tariff Refund.

Quarterly earnings-analysis entry for MDLN. Use the links on the right to open the video or podcast episode.

YouTube Spotify Podcast Apple Podcasts Amazon Show iHeart Show YouTube Music